The A1762T/G1764A mutations enhance HBV replication by alternating viral transcriptome

Abstract

AbstractThe A1762T/G1764A mutations, one of the most common mutations in the hepatitis B virus basal core promoter, are associated with the progression of chronic HBV infection. However, effects of these mutations on HBV replication remains controversial. This study aimed to systematically investigate the effect of the mutations on HBV replication and its underlying mechanisms. Using the prcccDNA/pCMV‐Cre recombinant plasmid system, a prcccDNA‐A1762T/G1764A mutant plasmid was constructed. Compared with wild‐type HBV, A1762T/G1764A mutant HBV showed enhanced replication ability with higher secreted HBV DNA and RNA levels, while Southern and Northern blot indicated higher intracellular levels of relaxed circular DNA, single‐stranded DNA, and 3.5 kb RNA. Meanwhile, the mutations increased expression of intracellular core protein and decreased the production of HBeAg and HBsAg. In vitro infection based on HepG2‐NTCP cells and mice hydrodynamic injection experiment also proved that these mutations promote HBV replication. 5′‐RACE assays showed that these mutations upregulated transcription of pregenomic RNA (pgRNA) while downregulating that of preC RNA, which was further confirmed by full‐length transcriptome sequencing. Moreover, a proportion of sub‐pgRNAs with the potential to express polymerase were also upregulated by these mutations. The ChIP‐qPCR assay showed that A1762T/G1764A mutations created a functional HNF1α binding site in the BCP region, and its overexpression enhanced the effect of A1762T/G1764A mutations on HBV. Our findings revealed the mechanism and importance of A1762T/G1764A mutations as an indicator for management of CHB patients, and provided HNF1α as a new target for curing HBV‐infected patients.